Evidence map›Paper›PMID 35501420›Full record

ArticleWorld journal of microbiology & biotechnology2022

Antimicrobial efficacy of in vitro and ex vivo photodynamic therapy using porphyrins against Moraxella spp. isolated from bovine keratoconjunctivitis.

M G Seeger, C S Machado, B A Iglesias, F S F Vogel, J F Cargnelutti

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of microbiology & biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Antimicrobial photodynamic therapy using tetra-cationic porphyrins with peripheral platinum(II) and palladium(II) complexes against multidrug-resistant bacteria isolated from canine otitis.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

M G SeegerPrograma de Pós-Graduação em Medicina Veterinária, Universidade Federal de Santa Maria (UFSM), Santa Maria, RS, Brazil.
C S MachadoPrograma de Pós-Graduação em Medicina Veterinária, Universidade Federal de Santa Maria (UFSM), Santa Maria, RS, Brazil.
B A IglesiasLaboratório de Bioinorgânica e Materiais Porfirínicos, Departamento de Química, UFSM, Santa Maria, RS, Brazil.
F S F VogelDepartamento de Medicina Veterinária Preventiva (DMVP), Centro de Ciências Rurais (CCR), UFSM, Santa Maria, RS, Brazil.
J F CargneluttiDepartamento de Medicina Veterinária Preventiva (DMVP), Centro de Ciências Rurais (CCR), UFSM, Santa Maria, RS, Brazil. jucargnelutti@gmail.com.ORCID http://orcid.org/0000-0002-3160-3643
Universidade Federal de Santa Maria · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infectious bovine keratoconjunctivitis (IBK) is an ocular disease affecting bovine herds worldwide, and it causes significant economic loss. The etiologic agent of IBK is considered to be Moraxella bovis, but M. ovis and M. bovoculi are frequently recovered of animals presenting clinical signs of IBK. The therapeutic measures available for its control have limited efficacy. Antimicrobial photodynamic therapy (aPDT) using porphyrins as photosensitizing molecules is an alternative method that can be used to reduce microbial growth. We evaluated the antibacterial activity of aPDT using two water-soluble tetra-cationic porphyrins (H

Indexed as

Anti-Infective AgentsCattle DiseasesKeratoconjunctivitisKeratoconjunctivitis, InfectiousMoraxellaceae InfectionsPhotochemotherapyPorphyrinsAnimalsAnti-Bacterial AgentsCattleMoraxellaSheepAnti-Bacterial AgentsAnti-Infective AgentsPorphyrinsaPDTCationic porphyrinsMoraxellaPhotoinactivationPink eye

Identifiers

PMID35501420
OpenAlexW4225392317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.